Hinev A, Klissarova A, Ghenev P, Kolev N, Chaushev B, Chankov P, Anakievski D, Dyakov S, Stratev S, Deliisky T
Third Clinic of Surgery, Division of Urology, St. Marina University Hospital, Varna, Bulgaria.
J BUON. 2009 Oct-Dec;14(4):661-7.
To explore the efficacy of a radioisotopic (RI) method in detecting sentinel lymph nodes (SLNs), known as sites of harboring metastases, in localized high-risk prostate cancer (HRPC).
The RI method was applied to 26 males with clinically localized HRPC, subjected to radical prostatectomy in 2006-2008. All had poor pathological characteristics: initial PSA > 15 ng/ml, Gleason score > 7, clinically suspected extracapsular extension, seminal vesicle invasion, and/or positive pelvic lymph nodes (LNs). The radiopharmaceutical (Tc-99m) was injected preoperatively at 4 zones of the periphery of the prostate. Tc-99m-nanocolloid particles were <or= 80 nm in size, with total activity of 3 mCi (111 MBq), diluted in 2 mL. One hour after Tc-99m administration, a planar scintigraphy was performed on a gamma camera in anterior, posterior and lateral projections. A high resolution collimator was used, gathering impulses up to 300,000 per frame. The precise location of the SLNs was determined intraoperatively by a gamma probe. The LNs removed by extended pelvic lymphadenectomy were arranged on an anatomical template, examined ex vivo by the gamma probe and scanned again. The LNs were cleaned from the adjacent fatty tissue, fixed in neutral formalin, and then processed separately for histological and immunohistochemical examination.
The number of surgically removed LNs ranged from 9 to 38 (mean 13), and the SLNs from 1 to 7 (mean 3). The SLNs were visualized on lymphoscintigraphy as strictly defined, round zones of high activity and were easily recognized intraoperatively by the gamma probe. The scintigraphic images of the scanned anatomical templates correlated well with those prior to surgery. Histology confirmed LN metastases in 11 cases. 94% of the metastatic LNs were SLNs, accurately detected by the RI method. Only 2 metastatic LNs showed no activity prior to, and during the operation. Most of the metastatic LNs (62%) were SLNs, located out of the obturator fossa.
The radioisotopic detection of the SLNs in HRPC is an objective and sensitive method that aids the surgeon to take a proper decision regarding the scope of the pelvic LN dissection in each particular case.
探讨放射性同位素(RI)方法在检测局限性高危前列腺癌(HRPC)中前哨淋巴结(SLN)(已知为转移灶所在部位)方面的疗效。
将RI方法应用于2006 - 2008年接受根治性前列腺切除术的26例临床局限性HRPC男性患者。所有患者均具有不良病理特征:初始前列腺特异性抗原(PSA)> 15 ng/ml, Gleason评分> 7,临床怀疑包膜外侵犯、精囊侵犯和/或盆腔淋巴结(LN)阳性。术前在前列腺周边的4个区域注射放射性药物(锝-99m)。锝-99m纳米胶体颗粒大小≤80 nm,总活度为3毫居里(111兆贝可),用2毫升稀释。给予锝-99m一小时后,在γ相机上进行前位、后位和侧位投影的平面闪烁显像。使用高分辨率准直器,每帧采集脉冲数达300,000。术中用γ探头确定SLN的精确位置。通过扩大盆腔淋巴结清扫术切除的LN排列在解剖模板上,用γ探头进行离体检查并再次扫描。将LN从相邻脂肪组织中清理出来,固定在中性福尔马林中,然后分别进行组织学和免疫组化检查。
手术切除的LN数量为9至38个(平均13个),SLN数量为1至7个(平均3个)。SLN在淋巴闪烁显像中表现为严格界定的、圆形的高活性区域,术中很容易通过γ探头识别。扫描的解剖模板的闪烁显像图像与手术前的图像相关性良好。组织学证实11例有LN转移。94%的转移LN是SLN,通过RI方法准确检测到。只有2个转移LN在手术前和手术期间无活性。大多数转移LN(62%)是SLN,位于闭孔窝外。
HRPC中SLN的放射性同位素检测是一种客观、敏感的方法,有助于外科医生在每个特定病例中就盆腔LN清扫范围做出恰当决策。